BSECompany Update4d ago · 4 Nov 2026, 08:43 pm
Intimation of Merger of Wholly owned subsidiary i.e KHPL with its holding company i.e Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Ltd · 543308
✦ AI SummaryM&A
Krishna Institute of Medical Sciences Ltd has announced the merger of its wholly-owned subsidiary, KIMS Hospitals Private Limited, with the company under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Attachments (1)
📄pdf
Download →
acfde688-b005-4662-b910-6eefdbbd0260.pdf
View document text
04th November, 2026
The Secretary, The Secretary,
Bombay Stock Exchange Ltd (BSE) National Stock Exchange,
Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Plot
Dalal Street, No.C/1, 'G' Block Bandra - Kurla
Mumbai - 400 001. Complex
Scrip Code - 543308 Mumbai - 400 051.
ISIN: INE967H01025 Symbol - KIMS
ISIN: INE967H01025
Dear Sir/ Madam
Sub: Intimation of Merger of wholly-owned subsidiary KIMS Hospitals Private Limited
(Transferor Company) with its Holding Company i.e. Krishna Institute of Medical Sciences
Limited (Transferee Company) under Regulation 30 of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015,and on the recommendation made by the
Audit committee, the Board of Directors of the Krishna Institute of Medical Sciences Limited (the
Company) at their meeting held today i.e. 04th November, 2026, has approved the scheme of
amalgamation between its wholly-owned subsidiary i.e KIMS Hospitals Private Limited (Transferor
Company) with its Holding Company i.e. Krishna Institute of Medical Sciences Limited (Transferee
Company) in accordance with the provisions of the Companies Act, 2013 and other applicable laws.
The requisite disclosure as per SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure-A to this letter.
Kindly take the above on your record.
The same is also uploaded on the Company’s website at: https://www.kimshospitals.com/investors/ >
Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the
Company > Intimations under Regulation 30.
Thanking You,
Yours truly
For Krishna Institute of Medical Sciences Limited
Nagajayanthi J.R
Company Secretary and Compliance Officer
ANNEXURE – A
1. Name of the entity(ies) KIMS HOSPITALS PRIVATE LIMITED (TRANSFEROR
forming part of the COMPANY):- Transferor Company is a wholly-owned subsidiary of Krishna
amalgamation/merger, Institute of Medical Sciences Limited. The paid up Capital of the Company is
details in brief such as, 6,59,99,999 Equity Shares of Rs. 10/- each amounting to Rs. 65,99,99,990/-
size, turnover etc.;
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED
(TRANSFEREE COMPANY):- Transferee Company is a holding Company
of KIMS Hospitals Private Limited. The paid up Capital of the Company is
42,00,06,484 Equity Shares of Rs. 2/- each amounting to Rs. 84,00,12,968/-.
(Rs. in millions)
Name of Company Turnover as PAT as on
on 31.03.2026
31.03.2026
KIMS Hospitals Private Limited Nil (5)
Krishna Institute Of Medical Sciences 17,015 2,607
Limited
2. Whether the transaction Y es,
would fall within related
party transactions? If However, pursuant to Regulation 23(5)(b) of the SEBI (Listing Obligations
yes, whether the same is and Disclosure Requirements) Regulations, 2015, this related party transaction
done at “arm’s length entered into between a holding Company and its wholly-owned subsidiary is
exempted.
3. Area of business of the The Transferor and Transferee Companies are engaged in Healthcare Activities
entity(ies);
4. Rationale for • Simplification of the group corporate structure and elimination of
amalgamation/ merger; multiple legal entities.
• Achieving operational and administrative efficiencies by pooling
resources and management functions.
• Optimizing utilization of assets, reduction in statutory compliances,
and cost savings.
• Strengthening the consolidated financial position and enhancing
shareholder value.
• Enabling focused management and unified decision-making.
5. In case of cash The Transferor Company is the wholly owned subsidiary of Transferee
consideration – amount company and hence there will be no cash consideration or issue of new
or otherwise share shares involved under the scheme of Amalgamation/merger.
exchange ratio;
6. Brief details of change in Not applicable.
shareholding pattern (if
any) of listed entity. The shareholding pattern of the Transferee Company remains unchanged.